Journal retracts 2013 gastric cancer study over unreliable data
Pathology and Oncology Research retracted a 2013 paper on Semaphorin 5A and gastric cancer after an investigation raised concerns over data integrity.
FTMQ Science, written by our newsroom2 views
The journal Pathology and Oncology Research retracted a 2013 study on gastric cancer on 9 November 2026, according to Bioengineer.org. The paper claimed that the protein Semaphorin 5A enhances the invasion and metastasis of human gastric cancer cells by activating matrix metalloproteinase 9, also known as MMP9. Metastasis refers to the process by which cancer cells spread from the primary tumor to secondary sites in the body. [1]
Bioengineer.org reported that the journal retracted the paper because the Editor-in-Chief determined that its data and conclusions were unreliable. The decision followed an official investigation into the integrity of the published images, which revealed duplicate figures within the study. [1]
The retracted paper was originally authored by G. Pan, X. Zhang, J. Ren, J. Lu, W. Li, H. Fu, S. Zhang, and J. Li, as reported by Bioengineer.org. The paper was first published in 2013 in Pathology and Oncology Research. [1]
The action follows similar data integrity retractions at the same publication, as FTMQ Science reported earlier. In August 2026, Pathology and Oncology Research retracted a 2018 study on osteosarcoma after the authors disclosed improper image cropping that invalidated the findings on the Sox2 gene. [4]
In short
- Pathology and Oncology Research retracted the 2013 gastric cancer study on 9 November 2026.
- The retraction followed an investigation by the journal Editor-in-Chief that found duplicate figures.
- The study originally claimed that Semaphorin 5A enhanced gastric cancer metastasis via MMP9 activation.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Gastric Cancer Study Retracted Over Duplicate FiguresBioengineer.org, 8d ago (the report this story comes from)
Background
- [2]Research paper mill on Wikipedia
- [3]Gormiti on Wikipedia
- [4]Journal retracts 2018 bone cancer paper following image manipulation FTMQ Science, 32d ago
Our newsroom writes these reports with the help of software, from the 4 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Science
Earlier reports of ours on the same people and subjects.
- Frontiers in Physiology retracts 2021 diabetic kidney disease paperNew Research, 4d ago
- Journal retracts 2018 bone cancer paper following image manipulationNew Research, 32d ago
- Frontiers retracts 2020 rat brain study over unreliable dataNew Research, 22d ago
- Archives of Gynecology and Obstetrics retracts mini sling trialNew Research, 7d ago
- Medical journal retracts and republishes study on Long COVID treatmentsNew Research, 33d ago
More in New Research
- Chronic loneliness increases dementia risk by 38 percent in older adults5h ago
- Vitamin B12 reverses developmental defects in model of rare genetic disorder1d ago
- Wildfires increase concurrent exposure to ozone and fine particulate pollutants1d ago
- Hyperscale data centers consume two percent of total United States electricity1d ago
- Global fire activity dropped by over twelve percent during pandemic lockdowns2d ago
- Vitamin C may block stomach cancer chemicals, model shows2d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.